Depression Symptoms Greater in Mothers With Prior Eating Disorders
Women with eating disorders experience persistently greater depressive symptoms across the life-course.
Home
Review Investigates Adverse Effects of Cannabidiol
The use of cannabidiol (CBD), the non-intoxicating component of cannabis, has been associated with numerous adverse effects based on available evidence from animal and human studies.
FDA Fast-Track Approval of Evzio for Opioid Overdose Reversal
The US Food and Drug Administration has provided fast-track approval for the nonclinician use of Evzio, an easy-to-use autoinjectable device with a single dose of naloxone for the reversal of opioid overdose.
Associations Between Migraine and Psychiatric Comorbidities, Implications for Treatment
There may be a bidirectional association between migraine and some comorbid psychiatric disorders.
Prescription Opioid Use Linked to Binge Drinking
Prescription opioid misuse is more common among binge drinkers, with the prevalence of opioid misuse increasing with binge drinking frequency.
Exposure to Air Pollution May Affect Children’s Cognitive Abilities
Early-life exposure to fine particulate matter (PM2.5) is associated with a reduction in fundamental cognitive abilities.
Methylphenidate Beneficial in ADHD After 2 or More Years
Current guidelines include recommendations on how to prescribe methylphenidate, but lack of recommendations regarding the long-term use of the drug.
No Significant Differences Between CBT Delivery Formats for Depression
Researchers found data that showed facilitated therapy for individuals, groups, by telephone, and CBT is more effective than unguided self-help.
Virtual Reality Tool Assesses Functional Capacity in Early Schizophrenia
Researchers found data that showed young patients in the early phase of schizophrenia would benefit by the Virtual Reality Functional Capacity Assessment Tool, as a measure to track changes in response to treatment.
Predictors of Remission in Schizophrenia or Schizoaffective Disorder
In The Netherlands, researchers found data that showed remission in patients with schizophrenia who are aged 60 or older correlates with having a partner and less intense positive symptoms.
Want to read more?
Please login or register first to view this content.
Next post in Schizophrenia Advisor
